Soft Tissue Sarcoma
📧 Sign up to get email alerts when something new happens for Soft Tissue Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-03-30Clinical Trial Update: Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors [Phase 2]
Phase 2 trial results for cixutumumab in relapsed or refractory solid tumors across multiple sarcomas and pediatric cancers.
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors [Phase 1]
A phase 1 trial evaluating everolimus in pediatric patients with recurrent or refractory tumors, including brain tumors, rhabdomyosarcoma, a…
-
CLINICAL_TRIALS trial_result · 2015-03-02Clinical Trial Update: Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma [Phase 2]
This clinical trial update reports Phase 2 results for glufosfamide in previously treated advanced soft tissue sarcoma, focusing on safety a…
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating nelfinavir mesylate in adults with liposarcoma (recurrent, metastatic, or unresectable soft tissue sarcoma) was t…
-
CLINICAL_TRIALS trial_result · 2015-02-13Clinical Trial Update: Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED) [Phase 2]
This update reports the completion of a Phase 2 trial of ridaforolimus (AP23573/MK-8669), an mTOR inhibitor, in patients with advanced sarco…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: iCAT for Recurrent/Refractory/HR Solid Tumors
A completed clinical trial evaluating iCAT for recurrent/refractory/high-risk solid tumors in pediatric patients, including Neuroblastoma, W…
-
CLINICAL_TRIALS trial_result · 2014-12-29Clinical Trial Update: A Phase I/II Clinical Trial of PXD101 in Combination With Doxorubicin in Patients With Soft Tissue Sarcomas [Phase 1, Phase 2]
Phase I/II study evaluating panobinostat (PXD101) in combination with doxorubicin for soft tissue sarcoma; the trial completed with results …
-
CLINICAL_TRIALS trial_result · 2014-12-11Clinical Trial Update: Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery [Phase 1]
A Phase 1 trial of autologous T cells combined with cyclophosphamide in adults with metastatic or unresectable soft tissue sarcoma (includin…
-
CLINICAL_TRIALS trial_result · 2014-11-25Clinical Trial Update: Huntsman Biopsy Study
The Huntsman Biopsy Study (NCT00615329) has been terminated according to the latest clinical trial status update.
-
CLINICAL_TRIALS trial_result · 2014-11-24Clinical Trial Update: Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma [Phase 2]
Phase 2 trial comparing two chemotherapy regimens for soft tissue sarcoma, focusing on side effects and relative activity; results completed…
-
FDA approval · 2014-11-18FDA Approved: VOTRIENT — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for VOTRIENT (pazopanib hydrochloride) from Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2014-11-14Clinical Trial Update: Ixabepilone in Treating Young Patients With Refractory Solid Tumors [Phase 2]
Phase 2 trial update on ixabepilone in young patients with refractory solid tumors. The study status is completed.
-
FDA approval · 2014-11-05FDA Approved: DOXORUBICIN HYDROCHLORIDE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for doxorubicin hydrochloride (Fresenius Kabi USA, LLC) under anANDA to support its generic product.
-
CLINICAL_TRIALS trial_result · 2014-10-27Clinical Trial Update: Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma [Phase 3]
A Phase 3 trial comparing doxorubicin with or without ifosfamide and pegfilgrastim for locally advanced or metastatic soft tissue sarcoma ha…
-
CLINICAL_TRIALS trial_result · 2014-10-08Clinical Trial Update: Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue Sarcoma [Phase 1, Phase 2]
A Phase 1/2 trial tested everolimus in combination with imatinib mesylate in adults with locally advanced, recurrent, or metastatic soft tis…
-
CLINICAL_TRIALS research · 2014-09-25Clinical Trial Update: Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas. [Phase 2]
A Phase 2 trial evaluating the combination of docetaxel and irinotecan (DI) for recurrent or refractory bone and soft tissue sarcomas; the c…
-
CLINICAL_TRIALS trial_result · 2014-08-28Clinical Trial Update: Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone Sarcoma [Phase 2]
Phase 2 trial evaluating dexrazoxane with combination chemotherapy followed by surgery and radiation for advanced soft tissue sarcoma or rec…
-
CLINICAL_TRIALS trial_result · 2014-08-08Clinical Trial Update: Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS) [Phase 2]
A Phase 2 trial evaluating radiation therapy in combination with intratumoral autologous dendritic cells for soft tissue sarcoma has complet…
-
CLINICAL_TRIALS trial_result · 2014-08-08Clinical Trial Update: Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma [Phase 3]
A Phase 3 clinical trial sponsored by the European Organisation for Research and Treatment of Cancer (EORTC) comparing surgery with and with…
-
CLINICAL_TRIALS trial_result · 2014-08-08Clinical Trial Update: Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma [Phase 2, Phase 3]
A phase 2/3 trial comparing doxorubicin hydrochloride to trabectedin for previously untreated advanced or metastatic soft tissue sarcoma has…
-
CLINICAL_TRIALS research · 2014-08-08Clinical Trial Update: Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma [Phase 2]
Phase II clinical trial evaluating brostallicin or doxorubicin as first-line therapy for relapsed, refractory, or metastatic soft tissue sar…
-
CLINICAL_TRIALS research · 2014-08-05Clinical Trial Update: Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma
This entry reports the completion of a genetic study in pediatric patients with soft tissue sarcoma or rhabdomyosarcoma conducted by the Chi…
-
CLINICAL_TRIALS trial_result · 2014-07-25Clinical Trial Update: Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma [Phase 2]
Phase 2 trial assessing a multimodal treatment (chemotherapy, surgery, and radiation) for children with advanced soft tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma [Phase 2]
Phase 2 trial assessing intensity-modulated radiation therapy for soft tissue sarcoma patients undergoing surgery; the study was terminated …
-
CLINICAL_TRIALS trial_result · 2014-07-04Clinical Trial Update: Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology [NA]
Clinical trial update on aspirin and compression devices for venous thromboembolism prophylaxis in orthopaedic oncology completed, with resu…